Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
| Title: | Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab. |
|---|---|
| Authors: | Hesselvig JH; Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, University of Copenhagen, Kildegaardsvej 28, DK-2900 Hellerup, Denmark. jeanettehalskou@gmail.com.; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L |
| Source: | Acta dermato-venereologica [Acta Derm Venereol] 2018 Mar 13; Vol. 98 (3), pp. 335-339. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2024- : Uppsala, Sweden : MJS Publishing; Original Publication: Stockholm : Acta dermato-venereologica |
| MeSH Terms: | Quality of Life* ; Surveys and Questionnaires*; Dermatologic Agents/*therapeutic use ; Psoriasis/*drug therapy ; Skin/*drug effects ; Ustekinumab/*therapeutic use; Dermatologic Agents/adverse effects ; Psoriasis/diagnosis ; Psoriasis/psychology ; Skin/pathology ; Ustekinumab/adverse effects ; Adult ; Denmark ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries ; Remission Induction ; Severity of Illness Index ; Time Factors ; Treatment Outcome |
| Abstract: | Monitoring of biological treatment efficacy for psoriasis is based on clinical evaluation and patient's quality of life. However, long-term correlation between Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) in real life has not been studied in patients treated with ustekinumab. All patients with psoriasis treated with ustekinumab at our department were included (n = 120) in this study. Correlation analyses between the change in PASI and DLQI and the individual subquestions in DLQI were performed using Spearman's rank correlation coefficient. A correlation value of 0.57 (p-value |
| Substance Nomenclature: | 0 (Dermatologic Agents); FU77B4U5Z0 (Ustekinumab) |
| Entry Date(s): | Date Created: 20171108 Date Completed: 20180904 Latest Revision: 20260127 |
| Update Code: | 20260130 |
| DOI: | 10.2340/00015555-2833 |
| PMID: | 29110019 |
| Database: | MEDLINE |
Journal Article